Transcriptomics

Dataset Information

0

CD27 Agonism Enhances Long-Lived CD4⁺ T Cell Vaccine Responses Critical for 2 Anti-Tumor Immunity


ABSTRACT: Patients with metastatic breast cancer were vaccinated with dendritic cell (DC) vaccine targeting HER2, and all seven survived >18 years. PBMC analysis revealed HER2-specific CD27⁺ memory CD4⁺ and CD8⁺ T cells, suggesting that CD27 signaling supports durable immune memory. We tested this by combining an anti-CD27 agonist antibody (Varlilumab) with a HER2 vaccine, which enhanced HER2-specific responses, particularly long-lived CD4⁺ memory T cells detectable up to 300 days post-vaccination. CD27 agonism improved tumor control (~40% regression) compared to vaccine alone (~6%), and synergy with PD-1 blockade led to complete tumor rejection in ~90% of mice. CD4⁺ T cells were essential for this effect, as shown by depletion and adoptive transfer experiments, while CD8⁺ T cells played a less critical role. We utilized combined scRNA-seq and TCR sequencing to identify expanded clonotypes and increased CD8+ and CD4+ functional subsets with combined CD27 agonism and vaccination as well as vaccination alone. These findings demonstrate that antigen-specific huCD27⁺ CD4⁺ T cells are key effectors of vaccine-induced immunity and support CD27 agonism as a promising strategy to enhance therapeutic cancer vaccination.

ORGANISM(S): Mus musculus

PROVIDER: GSE305350 | GEO | 2026/02/10

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-10-10 | GSE244834 | GEO
2017-11-01 | GSE98640 | GEO
2015-09-23 | E-GEOD-73314 | biostudies-arrayexpress
2010-12-28 | E-GEOD-25456 | biostudies-arrayexpress
2020-07-10 | GSE129251 | GEO
2013-08-01 | E-GEOD-42459 | biostudies-arrayexpress
2022-11-30 | GSE214395 | GEO
2010-12-28 | GSE25456 | GEO
2013-07-10 | E-GEOD-30059 | biostudies-arrayexpress
2021-05-24 | GSE171783 | GEO